Skip to main content
VIKAS LIFECARE LIMITED logo

VIKAS LIFECARE LIMITED — Investor Relations & Filings

Ticker · VIKASLIFE ISIN · INE161L01027 LEI · 9845008856U9D9DABE98 BSE.NS Manufacturing
Filings indexed 504 across all filing types
Latest filing 2020-03-31 Regulatory Filings
Country IN India
Listing BSE.NS VIKASLIFE

About VIKAS LIFECARE LIMITED

https://www.vikaslifecarelimited.com

Vikas Lifecare Limited is a diversified enterprise specializing in the manufacturing and trading of polymer and rubber compounds, specialty additives, and chemicals. The company produces high-performance polymer compounds utilized in sectors such as footwear, automotive, and infrastructure. Beyond its core chemical business, it has expanded into the Fast-Moving Consumer Goods (FMCG) and agro-products markets, focusing on the processing and distribution of premium food products. The company also provides infrastructure solutions, specifically in the domain of smart gas metering. A key aspect of its operations is the integration of recycled materials into its production cycles, reflecting a commitment to sustainable manufacturing. Its strategic focus involves vertical integration and portfolio diversification to address evolving industrial and consumer demands.

Recent filings

Filing Released Lang Actions
Trading Window
Regulatory Filings Classification · 95% confidence The document is a short notice addressed to stock exchanges regarding the closure of the trading window in compliance with SEBI regulations ahead of the announcement of audited financial results for the fiscal year ended March 31, 2020. It does not contain any financial data or results itself, nor does it present a report. It is an announcement related to compliance and trading restrictions prior to the release of financial results. The document length is only 1103 characters, indicating it is a brief notice rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2020-03-31 English
Reply to Clarification- Financial results
Regulatory Filings Classification · 100% confidence The document text is extremely short (58 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, no report content, no announcements, or any other information to classify as a specific report type. Given the lack of content, the document does not fit any specific filing category and defaults to the fallback category for miscellaneous filings that do not fit elsewhere, which is Regulatory Filings (RNS).
2020-02-24 English
Demise
Regulatory Filings
2020-02-18 English
Change in Director(s)
Regulatory Filings
2020-02-12 English
Financial Result Updates
Regulatory Filings
2020-02-12 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 95% confidence The document is dated February 12, 2020, and is addressed to the Listing Compliance Department of NSE and BSE, indicating a regulatory filing context. It announces the approval of unaudited financial results for the third quarter and nine months ended December 31, 2019, pursuant to SEBI Listing Regulations. The document includes detailed financial data such as revenue, expenses, profit before tax, tax expenses, and earnings per share for the quarter and nine months, which are typical components of an interim or quarterly financial report. The presence of unaudited financial results and the period covered (quarter and nine months) confirm this is a quarterly/interim report rather than a full annual report or just an announcement. The document length (15,000 characters) and detailed financial tables further support this classification. Therefore, the document is best classified as an Interim / Quarterly Report (IR). 9M 2020
2020-02-12 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.